Osteoarthritis Trial, Recruiting NCT06592248 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06592248
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults under 70 years of age who were previously physically active and have knee osteoarthritis that significantly limits daily life
  • People whose knee osteoarthritis has not responded to standard treatments such as anti-inflammatory medications, injections, or pain relief medications
  • People who have a knee alignment problem (deformity) of less than 10 degrees, and this would be their first implant in that knee
  • People who have given written agreement to take part in the trial
  • People who are registered with the French social security system

Who may not be able to join:

  • People with a knee deformity greater than 10 degrees
  • People with a BMI (body mass index) over 30, which is classified as obesity
  • People with an inflammatory joint disease, such as rheumatoid arthritis
  • People with a history of joint infection
  • People with poor skin condition around the knee area
  • People with a known allergy to the materials used in the implant or to the anaesthetic used during surgery
  • People who have repeated falls, or significant neurological, mental, or neuromuscular conditions that could lead to complications after surgery
  • People with significant weakness or damage to the stabilising ligaments on the sides of the knee
  • Women who are pregnant, within 48 hours of giving birth, breastfeeding, or who test positive on a pregnancy test
  • People who have a strong fear of MRI scans and refuse to have one
  • People who cannot have an MRI scan for medical reasons, such as having an active implanted medical device or certain metal implants in the body
  • People who are under a legal protection order (confirm with trial site)
  • People who are currently taking part in another clinical trial
  • People whose osteoarthritis developed as a result of a previous bone fracture
  • People who have osteoporosis (weakened or brittle bones)
  • People whose bone shape or size is not compatible with the implant being used in this trial
  • People with another serious health condition that would prevent them from returning to physical activity after surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pascal BIZOT, MD, Pr, APHP

Phone: +33 (0)1 49 95 91 34

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 December 2024
Est. completion
19 December 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluation of clinical endpoint 1(Oxford score) at 12 months; Evaluation of clinical endpoint 2 (IKS score) at 12 months; Evaluation of clinical endpoint 3 (Forgotten Joint score) at 12 months; Evaluation of clinical endpoint 4 (Joint sounds) at 12 months; Evaluation of clinical endpoint 5 (Pain) at 12 months; Evaluation of clinical endpoint 6 (Knee mobility) at 12 months; Evaluation of clinical endpoint 7 (Knee stability) at 12 months; Evaluation of radiographic endpoints at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov